Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
GLP-1s are more than just weight loss drugs. They're a chance to rewrite our evolutionary story, to take control of our biology in a way never before possible.
With public understanding divided on the causes of obesity, this paper aims to transcend the debate between personal responsibility and disease status to offer a fresh perspective – that obesity is an evolutionary trap. Specifically, it examines:
- Why human biology creates an inherent vulnerability to obesity
- How amplifying our natural GLP-1 levels can address multiple different diseases
- The current status of GLP-1 drug approvals by condition
- The unprecedented questions we now face about equity, access & our collective future
![[WEBINAR] KEYS: Global Trends - The Uneasy Decade](/sites/default/files/styles/related_more_insights/public/ct/event/2025-09/thumbnail-templates_0.png?itok=Qh37M2xL)
![[WEBINAR] Canadian EV Adoption Trends in 2025](/sites/default/files/styles/related_more_insights/public/ct/event/2025-01/thumb.png?itok=RSGzZvMm)
![[WEBINAR] Sustainable Packaging: A Potential Avenue of Distinction](/sites/default/files/styles/related_more_insights/public/ct/event/2023-09/SustainablePackaging_WebR_feature%20copy.jpg?itok=X0DpNf_C)